Multimodality Therapy for Limited-Stage Small-Cell Lung Cancer [Clinical Reviews]

Limited-stage small-cell lung cancer (SCLC) occurs in only one third of patients with SCLC, but it is potentially curable. Combined-modality therapy (chemotherapy and radiotherapy) has long been the mainstay of therapy for this condition, but more recent data suggest a role for surgery in early-stage disease. Prophylactic cranial irradiation seems to improve outcomes in patients who have responded to initial therapy. This review addresses the practical aspects of staging and treatment of patients with limited-stage SCLC.
Source: Journal of Oncology Practice - Category: Cancer & Oncology Authors: Tags: Small Cell, Diagnosis & Staging, Surgery, Radiation, Chemotherapy, Combined Modality Clinical Reviews Source Type: research